Venus Remedies

Venus Remedies EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Venus Remedies (VENUSREM.NS) as of Nov 9, 2026 is 7.20. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 9.73 — a change of -25.98% (lower).

EV/FCF

7.20

YoY

-25.98%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Venus Remedies is 2026 7.20 . EV/FCF (Enterprise Value to Free Cash Flow) of Venus Remedies was 2025 9.73 . It decreases by -25.98% lower compared to the previous year.

The Venus Remedies EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2019
35.29 INR
Jan 1, 2020
16.93 INR
Jan 1, 2021
7.81 INR
Jan 1, 2022
34.84 INR
Jan 1, 2023
32.06 INR
Jan 1, 2024
32.57 INR
Jan 1, 2025
9.73 INR
Jan 1, 2026
7.20 INR
The Venus Remedies EV/FCF history
YEAREV/FCFYoY
7.20-25.98%
9.73-70.13%
32.57+1.57%
32.06-7.96%
34.84+345.89%
7.81-53.84%
16.93-52.03%
35.29+4.60%
33.73+31.79%
25.60-107.14%
-358.49-110.74%
3,336.94-11,393.07%
-29.55—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Venus Remedies Stock analysis

What does Venus Remedies do? Venus Remedies Ltd. manufactures and trades pharmaceutical products, focusing on injectables, tablets, and topical preparations for therapeutic segments including anti-infective, oncology, skin and wound care, and pain management. The company's brands such as Potentox, Vancoplus Combi, Tobracef, Supime, Zydotum, Neurotol, Trois, Septiloc, Mucomelt, Ventaful, and Nervolize cater to critical care and super specialty markets. Its product portfolio addresses antimicrobial resistance (AMR), oncology, neurology, anticoagulants, and herbal solutions, serving medicine, surgery, neuro, and orthopedics. The firm operates in the Pharmaceutical Formulation segment with three manufacturing facilities. The company sells its pharmaceutical products to healthcare providers and institutions globally, targeting critical care and super specialty segments. Brands like Potentox and Vancoplus Combi are positioned for antimicrobial resistance (AMR) solutions, while Neurotol and Trois serve neurology and orthopedics. Supime and Zydotum focus on pain management and skin care, and Septiloc and Mucomelt address anticoagulants and wound care. Venus Remedies' formulations include injectables, tablets, and topical preparations for diverse therapeutic needs. Venus Remedies Ltd. generates revenue through the sale of its branded pharmaceutical products, including injectables, tablets, and topical preparations. The company's product lines target specific therapy areas such as AMR, oncology, skin and wound care, and pain management, with brands like Ventaful and Nervolize supporting neurology and anticoagulant markets. The firm's global reach in injectable manufacturing and focus on super specialty segments drive its market positioning within the Pharmaceutical Formulation segment. Venus Remedies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Venus Remedies stock

EV/FCF (Enterprise Value to Free Cash Flow) of Venus Remedies is 7.20 in 2026.

EV/FCF (Enterprise Value to Free Cash Flow) of Venus Remedies changed from 9.73 to 7.20, representing a -25.98% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Venus Remedies since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Venus Remedies with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Venus Remedies

All Key Metrics — Venus Remedies